These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: In vitro and in vivo antimalarial activity of derivatives of 1,10-phenanthroline framework.
    Author: Yapi AD, Valentin A, Chezal JM, Chavignon O, Chaillot B, Gerhardt R, Teulade JC, Blache Y.
    Journal: Arch Pharm (Weinheim); 2006 Apr; 339(4):201-6. PubMed ID: 16586427.
    Abstract:
    A series of trisubstituted 1,10-phenanthrolines was prepared. These compounds exhibited mild to high biological activities in vitro both toward chloroquino-resistant FcB1-Columbia and FcM29-Cameron strains and Nigerian chloroquino-sensitive strain of Plasmodium falciparum. Cytotoxicity of the most active compounds was estimated showing that one compound (10) exhibited a selective activity against malaria parasite (selectivity indexes of 52 and 144). Antiplasmodial activity of this derivative was optimized by N-10 alkylation and the phenanthrolinium salt (15) submitted to an in vivo study using mice infected by P. vinckei petteri showing an ED50 of 7.86 mg/kg/day.
    [Abstract] [Full Text] [Related] [New Search]